At what age should Cologuard screening be discontinued in average‑risk adults?

Cologuard Screening Discontinuation Age

Cologuard and other colorectal cancer screening should be stopped at age 75 in average-risk adults who are up-to-date with prior screening, or when life expectancy falls below 10 years, whichever comes first. 1

Primary Stopping Age: 75 Years

• The U.S. Multi-Society Task Force, USPSTF, American College of Gastroenterology, and American Cancer Society all converge on age 75 as the standard stopping point for routine colorectal cancer screening in average-risk adults. 1

• The USPSTF provides a Grade A recommendation for screening ages 50-75, but downgrades to Grade C (selective offering) for ages 76-85, indicating the net benefit becomes small after 75. 1

• The American College of Physicians states clinicians should discontinue screening in average-risk adults older than 75 years or in those with life expectancy of 10 years or less. 2

Life Expectancy Consideration

• Life expectancy less than 10 years is an absolute threshold for stopping screening, regardless of age. 1

• This reflects the time lag between screening detection and mortality benefit—screening provides minimal value when patients are unlikely to live long enough to benefit from early cancer detection. 1

Ages 76-85: Selective Screening Only

• Between ages 76-85, screening should only be considered selectively, with the strongest consideration for those who have never been previously screened. 1, 3

• The decision in this age range must account for:

  • Overall health status and comorbidities 1
  • Prior screening history (those up-to-date with negative results gain minimal benefit) 1
  • Life expectancy greater than 10 years 1
  • Patient preferences regarding potential harms versus benefits 1

• The NCCN guidelines emphasize that eligible individuals aged 76-85 who have not been previously screened are most likely to experience benefit. 3

Age 85 and Beyond: Discontinue Screening

• All major guidelines recommend discouraging colorectal cancer screening after age 85. 1

• After 85, the harms and adverse events associated with colonoscopy and follow-up procedures outweigh any potential life expectancy benefits. 1

Common Pitfalls to Avoid

• Do not continue routine screening in patients aged 75+ simply because they are "healthy for their age"—the evidence shows diminishing returns even in healthier older adults who are up-to-date with screening. 1

• Avoid initiating new screening in patients over 75 who have been consistently screened with negative results—the yield is extremely low and harms increase. 1

• The exception is the never-screened patient aged 76-85 with good health and life expectancy >10 years, where selective screening may be reasonable. 1, 3